Raymond James Financial’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Raymond James Financial’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Buy	95,381 +3,986	+4%	+$118K	﹤0.01%	3145
2026 Q1	$2.65M	Sell	91,395 -12,645	-12%	-$368K	﹤0.01%	3126
2025 Q4	$2.95M	Buy	+104,040	New	+$2.83M	﹤0.01%	2944
2025 Q3	–	Sell	-7,032	Closed	-$149K	–	5772
2025 Q2	$149K	Buy	+7,032	New	+$144K	﹤0.01%	4665
2025 Q1	–	Sell	-41,261	Closed	-$888K	–	4877
2024 Q4	$888K	Buy	+41,261	New	+$952K	﹤0.01%	3530

Other funds holding IBBQ

WMS Group Folsom, Louisiana $77.5M AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

CFA

Churchill Financial Advisors Louisville, Kentucky $519M AUM

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial's IBBQ Position: Q2 2026 in Review

Raymond James Financial increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 4.4% in Q2 2026, buying an estimated $118K and bringing the position to 95,381 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3145.

Raymond James Financial first reported a position in IBBQ in Q4 2024 and has held it in 5 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

Raymond James Financial held 95,381 shares of Invesco NASDAQ Biotechnology ETF worth $3.12M as of Q2 2026.
Raymond James Financial bought 3,986 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $118K.
Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3145 holding.
Raymond James Financial first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2024 and has held it in 5 quarters since.
35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.